Photoelectric dye-coupled thin film as a novel type of retinal prosthesis

September 30, 2014, Okayama University
Figure 1. Photoelectric dye-coupled polyethylene film (OUReP): a novel type of retinal prosthesis.

Eye doctor Dr. Toshihiko Matsuo and polymer science engineer Dr. Tetsuya Uchida have been developing a new type of retinal prosthesis that is based on a photoelectric dye. The photoelectric dye is an organic molecule that absorbs light and converts light energy into electric potentials. The dye molecules are coupled to the surface of a film made of polyethylene. The polyethylene film (or polymer) is a biologically safe and stable material which is used, for example, as a component of artificial joints. The photoelectric dye-coupled polyethylene film, called Okayama University-type retinal prosthesis or OUReP, can be implanted beneath the retina as a substitute for photoreceptor cells.

The photoreceptor cells in the retina absorb light and generate membrane potential changes as an initial process in sight. Patients with a hereditary disease called retinitis pigmentosa, gradually lose the photoreceptor cells in their lifetime and become totally blind. These vision-impaired patients are known to maintain other that connect to the brain. Thus, the implantation of something artificial called retinal prosthesis to replace the lost , would lead to the recovery of vision in blind patients.

A prevailing type of retinal prosthesis is the so-called "camera-image-capture and electrode-array output system". The image is captured by a digital video camera attached to glasses, and converted to electric signals. These signals are transmitted to a receiver implanted in the body, and finally, electric currents are outputted from an electrode array that is implanted around the degenerated retina. In 2013, Argus II Retinal Prosthesis System, by Second Sight, Inc., which uses this camera-capture and electrode-array system, was approved by the US Food and Drug Administration (FDA).

Okayama University-type —OUReP—would provide the following advantages over the Argus II Retinal Prosthesis System. First of all, OUReP does not require a camera or data processing system, or wiring to the retina. A single sheet of OUReP would be implanted into the subretinal space by currently-used standard vitreous surgery, just as to treat retinal detachment. A large size of the thin film, up to 10 mm in diameter, could be implanted in the eye, which would provide a wide visual field. Dye molecules in high density on the polyethylene surface work as both an image (light)-receiver and a neuron-stimulator, leading to high resolution of images. In contrast, the Argus II System with 60 electrodes provides low resolution of images.

Figure 2. Manufacturing process of photoelectric dye-coupled polyethylene film (OUReP): a novel type of retinal prosthesis.

The biological safety of OUReP has been already proven by standardized tests, based on ISO 10993, "Biological evaluation of ". In addition, the photoelectric dye, used for OUReP, has no toxicity at all. Rats with , called RCS rats, had their vision restored by subretinal implantation of OUReP. Manufacturing and quality control has been established at the laboratory of Polymer Materials Science in a Faculty-of-Engineering Building. Dr. Matsuo and Dr. Uchida are now preparing a first-in-human clinical trial at Okayama University Hospital, in consultation with Pharmaceuticals and Medical Devices Agency (PMDA, counterpart of US FDA), based on the Pharmaceutical Affairs (Pharmaceuticals and Medical Devices) Act in Japan.

Figure 3. Fast on-off response to light of electric potentials on the surface of photoelectric dye-coupled polyethylene film (OUReP): a novel type of retinal prosthesis.
Figure 4. Schematic drawing of vitreous surgery to implant a sheet of photoelectric dye-coupled polyethylene film (OUReP) , a novel type of retinal prosthesis, beneath the retina.

Explore further: New device offers hope to people blinded due to incurable eye disorders

More information: Matsuo T, Uchida T, Takarabe K. Safety, efficacy, and quality control of a photoelectric dye-based retinal prosthesis (Okayama University-type retinal prosthesis) as a medical device. J Artif Organs 2009;12:213-225.

Alamusi, Matsuo T, Hosoya O, Tsutsui MK, Uchida T. Behavior tests and immunohistochemical retinal response analyses in RCS rats with subretinal implantation of Okayama University-type retinal prosthesis. J Artif Organs 2013;16 :343-351.

Related Stories

New device offers hope to people blinded due to incurable eye disorders

November 17, 2013
Research presented at the 117th Annual Meeting of the American Academy of Ophthalmology shows promising data about a device that helps people who have lost their vision due to a blinding genetic disease to recognize common ...

Eye implants make vision-restoring progress

July 18, 2012
(Medical Xpress) -- "I was blind once but now I can see.” The words are no longer the sole property of religious testimony and literature. Medical progress is being made in the restoration of vision as evidenced by Second ...

Bionic eye gives hope to the blind

February 5, 2013
After years of research, the first bionic eye has seen the light of day in the United States, giving hope to the blind around the world.

Making artificial vision look more natural

June 5, 2014
In laboratory tests, researchers have used electrical stimulation of retinal cells to produce the same patterns of activity that occur when the retina sees a moving object. Although more work remains, this is a step toward ...

Recommended for you

Precision neuroengineering enables reproduction of complex brain-like functions in vitro

November 14, 2018
One of the most important and surprising traits of the brain is its ability to dynamically reconfigure the connections to process and respond properly to stimuli. Researchers from Tohoku University (Sendai, Japan) and the ...

Gene mutation found to cause macrocephaly and intellectual deficits

November 13, 2018
The absence of one copy of a single gene in the brain causes a rare, as-yet-unnamed neurological disorder, according to new research that builds on decades of work by a University at Buffalo biochemist and his colleagues.

Can scientists change mucus to make it easier to clear, limiting harm to lungs?

November 12, 2018
For healthy people, mucus is our friend. It traps potential pathogens so our airways can dispatch nasty bugs before they cause harm to our lungs. But for people with conditions such as cystic fibrosis (CF) and chronic obstructive ...

Scientists uncover new gatekeeper function of anti-aging molecule

November 12, 2018
The protein klotho has been shown to promote longevity and counteract aging-related impairments. Having more klotho seems to allow for longer and healthier lives, whereas a depletion of this molecule accelerates aging and ...

Mutations, CRISPR, and the biology behind movement disorders

November 12, 2018
Scientists at the RIKEN Center for Brain Science (CBS) in Japan have discovered how mutations related to a group of movement disorders produce their effects. Published in Proceedings of the National Academy of Sciences, the ...

Researchers explain how your muscles form

November 12, 2018
All vertebrates need muscles to function; they are the most abundant tissue in the human body and are integral to movement.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.